NEOG Neogen Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEOG

Price (delayed)

$11.78

Market cap

$2.57B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$3.18B

?
Relative Growth: Rel. Growth: 51
Relative Strength: Rel. Strength: 91
Relative Valuation: Rel. Valuation: 23
Relative Profitability: Rel. Profitability: 49

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has ...

Highlights
Neogen's net income has soared by 99% YoY and by 99% from the previous quarter
The EPS has soared by 99% year-on-year and by 99% since the previous quarter
The gross profit is up by 3.8% from the previous quarter but it is down by 3.1% YoY
The revenue has contracted by 2.7% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.neogen.com
Peers: IDXX ILMN TMO PACB

Key stats

What are the main financial stats of NEOG

NEOG stock price

How has the Neogen stock price performed over time
Intraday
0.08%
1 week
-0.42%
1 month
2.52%
1 year
105.23%
YTD
68.53%
QTD
31.03%

Financial performance

How have Neogen's revenue and profit performed over time
Revenue
$870.4M
Gross profit
$408.5M
Operating income
-$21.6M
Net income
-$7.9M
Gross margin
46.9%
Net margin
-0.9%
Neogen's net income has soared by 99% YoY and by 99% from the previous quarter
The net margin has soared by 99% year-on-year and by 99% since the previous quarter
The company's operating income has surged by 98% YoY and by 97% QoQ
The operating margin has soared by 98% year-on-year and by 97% since the previous quarter

Price vs fundamentals

How does NEOG's price correlate with its fundamentals

Growth

What is Neogen's growth rate over time

Valuation

What is Neogen stock price valuation
NEOG P/E details
P/E
N/A
P/B
1.23
P/S
2.94
EV/EBIT
65.37
EV/EBITDA
18.63
EV/Sales
3.65
The EPS has soared by 99% year-on-year and by 99% since the previous quarter
The P/B is 54% more than the last 4 quarters average of 0.8 but 23% less than the 5-year quarterly average of 1.6
The price to sales (P/S) is 47% higher than the last 4 quarters average of 2.0 but 27% lower than the 5-year quarterly average of 4.0
The revenue has contracted by 2.7% YoY

Efficiency

How efficient is Neogen business performance
The ROS has soared by 109% since the previous quarter and by 105% year-on-year
The return on invested capital has surged by 109% since the previous quarter and by 105% year-on-year
The ROA has soared by 99% year-on-year and by 99% since the previous quarter
Neogen's return on equity has surged by 99% YoY and by 99% QoQ

Dividends

What is NEOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEOG.

Financial health

How did Neogen financials performed over time
The total assets is 167% more than the total liabilities
The quick ratio is up by 30% year-on-year and by 7% since the previous quarter
NEOG's current ratio is up by 15% YoY but it is down by 2.6% QoQ
The debt is 62% smaller than the equity
The company's debt to equity fell by 12% YoY
The debt is down by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.